Clinical characteristics and outcome of hospitalized patients with heart failure in Japan.
暂无分享,去创建一个
[1] C. Yancy,et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. , 2006, Journal of the American College of Cardiology.
[2] K. Swedberg,et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. , 2005, European heart journal.
[3] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[4] Karl Swedberg,et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. , 2005, European heart journal.
[5] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[6] K. Adams,et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.
[7] Y. Kagaya,et al. Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction--comparison with nonischemic cardiomyopathy. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[8] K. Swedberg,et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. , 2004, European heart journal.
[9] M. Pfeffer,et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme , 2003, The Lancet.
[10] N. Freemantle,et al. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. , 2003, European heart journal.
[11] Y. Kagaya,et al. Characteristics and 1-year prognosis of medically treated patients with chronic heart failure in Japan. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[12] N Freemantle,et al. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.
[13] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[14] Harlan M Krumholz,et al. Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.
[15] A. Takeshita,et al. Medical and socioenvironmental predictors of hospital readmission in patients with congestive heart failure. , 2001, American heart journal.
[16] A. Takeshita,et al. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. , 2001, The American journal of cardiology.
[17] A. Takeshita,et al. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure--a study in Fukuoka, Japan. , 2000, Japanese circulation journal.
[18] Joanne Eastaugh,et al. The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe , 2000, European journal of heart failure.
[19] ICHAEL,et al. THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE , 2000 .
[20] S G Thompson,et al. Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.
[21] L Goldman,et al. Correlates of early hospital readmission or death in patients with congestive heart failure. , 1997, The American journal of cardiology.
[22] B. Massie,et al. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. , 1997, American heart journal.
[23] Y Wang,et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.
[24] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[25] K. Bailey,et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. , 1993, Mayo Clinic proceedings.
[26] D. Levy,et al. Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.
[27] P E Leaverton,et al. Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.
[28] A. Itoh,et al. Prognosis of patients with congestive heart failure: its determinants in various heart diseases in Japan. , 1992, Internal medicine.
[29] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.